Signal #151763 · SEC 8-K

$RZLT SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $RZLT filing catalyst

Why did $RZLT trigger an AI stock catalyst alert?

$RZLT triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -0.5/10). Headline: Rezolute Reports Q1 FY2027 Net Loss of $18.5M, Cash at $90.0M. Key points: - Net loss of $18.5M or $0.18 per share for Q1 FY2027 vs. $18.2M ($0.18) in the prior year period. - Cash, equivalents, and marketable securities stood at $90.0M as of Sept 30, 2026, down from $107.8M in June. - Management expects to announce topline clinical results by mid-December 2026.

How did $RZLT stock react after the SEC filing?

After the SEC 8-K for $RZLT, observed market reaction: T0 price $3.64. Past moves do not guarantee future results.

Where can I get real-time $RZLT SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $RZLT via Telegram and the VIP Web Terminal from €10/month.

$RZLT

$RZLT – Rezolute Reports Q1 FY2027 Net Loss of $18.5M, Cash at $90.0M

Rezolute, Inc.

2026-11-05 00:00:00 UTC · SEC 8-K · All $RZLT

Unlocked archive · Analyzed in <2s at T0

Neutral AI Sentiment (-0.5 / 10)

Net loss of $18.5M or $0.18 per share for Q1 FY2027 vs. $18.2M ($0.18) in the prior year period.
Cash, equivalents, and marketable securities stood at $90.0M as of Sept 30, 2026, down from $107.8M in June.
Management expects to announce topline clinical results by mid-December 2026.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →